ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
eight
|
102 |
40K |
4 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
102
|
40K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
eight
|
10K |
3.3M |
2 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
10K
|
3.3M
|
2
|
|
ASX - By Stock
|
SPL |
Re:
IP value of Statpharma
|
|
eight
|
8 |
2.3K |
1 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
8
|
2.3K
|
1
|
|
ASX - By Stock
|
LLC |
Re:
Ann: S&P DJI Announces December 2022 Quarterly Rebalance
|
|
eight
|
2 |
974 |
3 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
2
|
974
|
3
|
|
ASX - By Stock
|
CMP |
Re:
Ann: Half Year Accounts
|
|
eight
|
37 |
15K |
4 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
37
|
15K
|
4
|
|
ASX - By Stock
|
AGL |
National electricity market - real time
|
|
eight
|
1 |
756 |
0 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
1
|
756
|
0
|
|
ASX - By Stock
|
AGL |
Re:
AGL Future Earnings
|
|
eight
|
433 |
180K |
13 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
433
|
180K
|
13
|
|
ASX - By Stock
|
UCM |
Re:
Ann: Appendix 4C - quarterly
|
|
eight
|
34 |
7.4K |
11 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
34
|
7.4K
|
11
|
|
ASX - By Stock
|
UCM |
Re:
Ann: Appendix 4C - quarterly
|
|
eight
|
34 |
7.4K |
2 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
34
|
7.4K
|
2
|
|
ASX - By Stock
|
UCM |
Re:
Ann: Appendix 4C - quarterly
|
|
eight
|
53 |
10K |
10 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
53
|
10K
|
10
|
|
ASX - By Stock
|
UCM |
Re:
Ann: Upcoming Investor Webinar
|
|
eight
|
10 |
2.9K |
6 |
12/07/20 |
12/07/20 |
ASX - By Stock
|
10
|
2.9K
|
6
|
|
ASX - By Stock
|
UCM |
Investor update in July
|
|
eight
|
0 |
354 |
9 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
0
|
354
|
9
|
|
ASX - By Stock
|
NAB |
Re:
NAB SPP
|
|
eight
|
328 |
188K |
4 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
328
|
188K
|
4
|
|
ASX - By Stock
|
NAB |
Re:
NAB SPP
|
|
eight
|
328 |
188K |
1 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
328
|
188K
|
1
|
|
ASX - By Stock
|
SGH |
Re:
Making SGH Great Again
|
|
eight
|
1.4K |
401K |
3 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.4K
|
401K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
I'm Confused
|
|
eight
|
17 |
5.9K |
5 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
17
|
5.9K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
eight
|
23K |
13M |
10 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
23K
|
13M
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
eight
|
23K |
13M |
23 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
23K
|
13M
|
23
|
|
ASX - By Stock
|
MSB |
Real patient review on Mesoblast treatment
|
|
eight
|
22 |
12K |
62 |
08/03/20 |
08/03/20 |
ASX - By Stock
|
22
|
12K
|
62
|
|
ASX - By Stock
|
LNK |
Re:
Where to now for Link
|
|
eight
|
517 |
1.1M |
1 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
517
|
1.1M
|
1
|
|
ASX - By Stock
|
LNK |
Re:
Where to now for Link
|
|
eight
|
517 |
1.1M |
16 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
517
|
1.1M
|
16
|
|
ASX - By Stock
|
BGA |
Re:
Bell Potter report 29.Oct.2019
|
|
eight
|
13 |
5.7K |
2 |
21/12/19 |
21/12/19 |
ASX - By Stock
|
13
|
5.7K
|
2
|
|
ASX - By Stock
|
BGA |
Re:
Bell Potter report 29.Oct.2019
|
|
eight
|
13 |
5.7K |
1 |
09/12/19 |
09/12/19 |
ASX - By Stock
|
13
|
5.7K
|
1
|
|
ASX - By Stock
|
BGA |
Bell Potter report 29.Oct.2019
|
|
eight
|
13 |
5.7K |
2 |
08/12/19 |
08/12/19 |
ASX - By Stock
|
13
|
5.7K
|
2
|
|
ASX - By Stock
|
BGA |
Re:
Could Bega be a TO target?
|
|
eight
|
12 |
8.2K |
8 |
07/12/19 |
07/12/19 |
ASX - By Stock
|
12
|
8.2K
|
8
|
|
ASX - By Stock
|
WBC |
Re:
SPP Today is start of 5 day price setting
|
|
eight
|
50 |
37K |
15 |
02/12/19 |
02/12/19 |
ASX - By Stock
|
50
|
37K
|
15
|
|
ASX - By Stock
|
NUF |
Quality socks at discount? Will Nufarm be acquired?
|
|
eight
|
0 |
662 |
0 |
04/06/19 |
04/06/19 |
ASX - By Stock
|
0
|
662
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Competition/ experiment..prediction of MSB price @ close of business June 28 2019
|
|
eight
|
135 |
54K |
2 |
09/04/19 |
09/04/19 |
ASX - By Stock
|
135
|
54K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter report - 28-Feb
|
|
eight
|
3 |
2.1K |
3 |
01/04/19 |
01/04/19 |
ASX - By Stock
|
3
|
2.1K
|
3
|
|
ASX - By Stock
|
MSB |
Bell Potter report - 28-Feb
|
|
eight
|
3 |
2.1K |
17 |
01/04/19 |
01/04/19 |
ASX - By Stock
|
3
|
2.1K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MSB short selling data - 25th.Jan.2019
|
|
eight
|
100 |
37K |
1 |
02/02/19 |
02/02/19 |
ASX - By Stock
|
100
|
37K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB short selling data - 25th.Jan.2019
|
|
eight
|
100 |
37K |
5 |
01/02/19 |
01/02/19 |
ASX - By Stock
|
100
|
37K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB short selling data - 25th.Jan.2019
|
|
eight
|
100 |
37K |
10 |
01/02/19 |
01/02/19 |
ASX - By Stock
|
100
|
37K
|
10
|
|
ASX - By Stock
|
MSB |
MSB short selling data - 25th.Jan.2019
|
|
eight
|
100 |
37K |
20 |
01/02/19 |
01/02/19 |
ASX - By Stock
|
100
|
37K
|
20
|
|
ASX - By Stock
|
MSB |
Bell Potter report - 16.Jan.2019
|
|
eight
|
15 |
9.3K |
15 |
18/01/19 |
18/01/19 |
ASX - By Stock
|
15
|
9.3K
|
15
|
|
ASX - By Stock
|
MSB |
We must explain strategy: Itescu
|
|
eight
|
22 |
8.3K |
32 |
08/01/19 |
08/01/19 |
ASX - By Stock
|
22
|
8.3K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Potential Market Size for Mesoblast products in US
|
|
eight
|
24 |
7.1K |
5 |
07/01/19 |
07/01/19 |
ASX - By Stock
|
24
|
7.1K
|
5
|
|
ASX - By Stock
|
MSB |
Potential Market Size for Mesoblast products in US
|
|
eight
|
24 |
7.1K |
16 |
07/01/19 |
07/01/19 |
ASX - By Stock
|
24
|
7.1K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
eight
|
4.4K |
2.4M |
21 |
05/01/19 |
05/01/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Meetings Held With FDA Support MSB's Planned GVHD Filing
|
|
eight
|
71 |
26K |
11 |
13/12/18 |
13/12/18 |
ASX - By Stock
|
71
|
26K
|
11
|
|
ASX - By Stock
|
MSB |
Bell Potter Report
|
|
eight
|
23 |
9.7K |
5 |
12/12/18 |
12/12/18 |
ASX - By Stock
|
23
|
9.7K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
eight
|
3.4K |
1.3M |
23 |
12/12/18 |
12/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
23
|
|
ASX - By Stock
|
CMP |
Re:
Ann: China JV Update
|
|
eight
|
20 |
9.7K |
5 |
25/10/18 |
25/10/18 |
ASX - By Stock
|
20
|
9.7K
|
5
|
|
ASX - By Stock
|
EYE |
Re:
Ann: ELX LEAD Clinical trial results
|
|
eight
|
67 |
22K |
2 |
21/09/18 |
21/09/18 |
ASX - By Stock
|
67
|
22K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Ann: ELX LEAD Clinical trial results
|
|
eight
|
67 |
22K |
2 |
20/09/18 |
20/09/18 |
ASX - By Stock
|
67
|
22K
|
2
|
|
ASX - By Stock
|
EYE |
2RT potential
|
|
eight
|
0 |
829 |
4 |
02/08/18 |
02/08/18 |
ASX - By Stock
|
0
|
829
|
4
|
|
ASX - By Stock
|
EYE |
iTrack - Chinese dream
|
|
eight
|
0 |
828 |
8 |
30/07/18 |
30/07/18 |
ASX - By Stock
|
0
|
828
|
8
|
|
ASX - By Stock
|
EYE |
MIGS: Minimally Invasive Glaucoma Surgery - Competitors
|
|
eight
|
0 |
358 |
1 |
28/07/18 |
28/07/18 |
ASX - By Stock
|
0
|
358
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Trading Update for Year Ended 30th June 2018
|
|
eight
|
6 |
4.6K |
10 |
28/07/18 |
28/07/18 |
ASX - By Stock
|
6
|
4.6K
|
10
|
|
ASX - By Stock
|
EYE |
Re:
2RT LEAD results June 2018
|
|
eight
|
7 |
5.8K |
5 |
05/06/18 |
05/06/18 |
ASX - By Stock
|
7
|
5.8K
|
5
|
|